Oocyte cryopreservation for fertility preservation of young woman in cancer, immune disease and the premature ovarian insufficiency

Oocyte cryopreservation for fertility preservation of young woman in cancer, immune disease and the premature ovarian insufficiency - Oocyte cryopreservation for fertility preservation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015910

Enrollment

Registered

2015-02-01

Start date

2015-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer patient including hematological malignancy, autoimmune disease such as SLE, premature ovarian insufficiency

Interventions

All the patients receive the same medical intervention Period (routine ovarian stimulation) Dosage of medicine (different among individuals) Number of times (1-2 times of oocyte pick up)

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Long-term survival is anticipated. 15 years or older 39 years or younger

Exclusion criteria

Exclusion criteria: An agreement is not obtained Patient who is judged to be inappropriate for this study Patient for whom the start of therapy may be significantly delayed for this study

Design outcomes

Primary

Measure	Time frame
Evaluation for a prospective advantage and disadvantage (including complication resulting from ovarian stimulation)	—

Countries

Japan

Contacts

Public ContactYasushi Takai

Saitama Medical Center, Saitama Medical University Department of Obstetrics and Gynecology

yastakai@saitama-med.ac.jp049-228-3681

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026